Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Cell Lysis And Fractionation Market Growth in 2025?

The market size of cell lysis and fractionation has seen a robust growth in the last few years. Projected to increase from $3.42 billion in 2024 to $3.72 billion in 2025, the market will experience a compound annual growth rate (CAGR) of 8.8%. The historical growth is linked to factors such as heightened investment in life science research, a growing emphasis on personalized medicine, a high incidence of diseases, advancements in cell lysis and fractionation technologies, as well as an increased demand for both biopharmaceuticals and biotechnology products.

What Is the Forecast for the Cell Lysis And Fractionation Market Size Through 2029?

The market for cell lysis and fractionation is anticipated to experience robust growth in the coming years, with its market size estimated to reach $4.89 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is ascribed to factors like the rising emphasis on personalized medicine, increased government backing for research, a strong demand for effective cell lysis and fractionation techniques, advancements in the realm of genomics and proteomics, and the increasing incidence of chronic and infectious diseases. Trends expected to shape the industry’s forecast period include sustained growth in the utilization of personalized medicine methodologies, growing incorporation of automation and robotics in lysis and fractionation procedures, widening of applications in clinical diagnostics and drug discovery, progress in microfluidics and lab-on-chip technologies for cell examination, and an increased focus on point-of-care and decentralized testing options.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

What are the Key Market Players in Cell Lysis And Fractionation Market and How They’re Evolving?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

What Are the Primary Growth Drivers in the Cell Lysis And Fractionation Market?

The increasing emphasis on personalized medicine is anticipated to drive the expansion of the cell lysis and fractionation markets in the future. Personalized medicine, a budding field in medical practice, utilizes a person’s genetic background for disease detection and treatment. This entails adapting healthcare decisions and treatments specifically to each patient, primarily based on their genetic composition. Cell lysis and fractionation are instrumental in precision medicine by facilitating the separation and examination of individual subcellular components from patient specimens, such as proteins, organelles, and nucleic acids. This allows scientists and healthcare experts to explore the molecular mechanisms that trigger disease and develop tailored treatments corresponding to each patient’s unique molecular characteristics. For example, as per the Personalized Medicine Coalition (PMC) – a U.S.-based association advocating for the comprehension and embracement of personalized medicine, over 75,000 genetic testing products and 300 personalized medicines specifically designed for individuals with diverse cancer types, rare genetic diseases, and a variety of chronic and infectious diseases, will be available on the market as of October 2022. Thus, the escalation in the emphasis on personalized medicine is fueling the expansion of the cell lysis and fractionation markets.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

What Are the Leading Segments in the Global Cell Lysis And Fractionation Industry?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

What Are the Key Market Trends in the Cell Lysis And Fractionation Industry?

The primary businesses within the cell lysis and fractionation market are innovating and presenting state-of-the-art solutions like CGT (cell and gene therapy) viral vector lysis kits, in an effort to outdo competitors. These kits provide a simpler AAV (Adeno-associated virus) lysis process that enhances standard operating procedures, safety measures, and quality checks while harmonizing bioprocessing operations. For example, in July 2023, QIAGEN, a leading sample and assay technology firm in Germany, introduced a new CGT Viral Vector Lysis Kit. This innovation enables the measurement of virus titers for multiple serotypes through a precise and consistent process utilizing cell lysates. The recent CGT viral vector lysis kit supplements QIAGEN’s swiftly growing digital PCR range for the biopharma sector. This range already includes three QIAcuity Residual DNA Quantification Kits that tests for the presence of host cell DNA residue and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays, utilized for adeno-associated virus (AAV) titer quantification.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

What Is the Regional Outlook for the Cell Lysis And Fractionation Market?

North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14064

This Report Delivers Insight On:

1. How big is the cell lysis and fractionation market, and how is it changing globally?

2. Who are the major companies in the cell lysis and fractionation market, and how are they performing?

3. What are the key opportunities and risks in the cell lysis and fractionation market right now?

4. Which products or customer segments are growing the most in the cell lysis and fractionation market?

5. What factors are helping or slowing down the growth of the cell lysis and fractionation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model